Here are four insights:
1. These drug increases are impacting both brand-name drugs and generics.
2. This price trend may be a consequence of drug research and development costs.
3. Others argue pharmaceutical companies are taking advantage of a “lack of bulk purchasing power.”
4. The Affordable Care Act is also not helping lowering drug prices.
More articles on quality & infection control:
Zika virus may be linked to eye damage in babies — 6 points
Zika virus impacts United Blood Services — 4 insights
Vascular surgery patients likely to quit smoking if offered personalized help from surgeons: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
